Data / Form D filings / Spartan Bioscience Inc.
Spartan Bioscience Inc.: Form D filings
Spartan Bioscience Inc., a biotechnology company in Nepean, Ontario, Canada, filed 3 Form D notices with the SEC between 2009 and 2013. The latest, on April 3, 2013, reports $24,000 sold of a $24,000 offering to 1 investor.
Find out what Spartan Bioscience Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 Gurdwara Road, Nepean, Ontario, Canada, K2E8A
- Phone
- (877) 228-7756
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1463231
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2013 | New notice | $24,000 | $24,000 | $0 | 1 | Aug 17, 2012 | sec.gov |
| May 16, 2012 | New notice | $110,000 | $110,000 | $0 | 1 | Dec 15, 2011 | sec.gov |
| May 4, 2009 | New notice | $150,000 | $150,000 | $0 | 1 | Apr 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Houghting | Executive Officer | |
| Michael Stork | Director | |
| Paul Markell | Executive Officer | |
| Michael Abrams | Executive Officer | |
| Jamie Spiegleman | Director | |
| John Lem | Director | |
| Paul Lem | Director | |
| Ken Paige | Director |
Every Form D from the week of Apr 1, 2013 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Spartan Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.